References
- Nielsen J, Damkier P, Lublin H, Taylor D. Optimizing clozapine treatment. Acta Psychiatr Scand 2011; 123:411–422. [Cited 4 July 2011.] Available from URL: http://dx.doi.org/ 10.1111/j.1600-0447.2011.01710.x
- Henderson DC, Dailey TB, Kunkel L, Rodrigues-Scott M, Koul P, Hayden D. Clozapine and hypertension: a chart review of 82 patients. J Clin Psychiatry 2004; 65:686–689.
- Novartis. Clozaril® (clozapine package insert). [Cited 4 July 2011.] Available from URL: http://www.pharma.us.novartis.com/product/pi/pdf/Clozaril.pdf
- Shiwach RS. Treatment of clozapine induced hypertension and possible mechanisms. Clin Neuropharmacol 1998; 21:139–140.
- Durst R, Raskin S, Katz G, Zislin J, Durst R. Pedal oedema associated with clozapine use. Isr Med Ass J 2000; 2:485–486.
- Drew LR. Controls on clozapine must be reviewed. Aust N Z J Psychiatry 2010; 44:490.
- Schulte PFJ, Cohen D, Bogers JPAM, Dijk van D, Bakker B. A Dutch guideline for the use of clozapine. Aust N Z J Psychiatry 2010;44:1055–1056.
- Visscher AJE, Cohen D. [in Dutch]. Tijdschr Psychiatr 2011;53:555–559.